Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 12)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03996369
Recruitment Status : Completed
First Posted : June 24, 2019
Last Update Posted : January 12, 2022
Information provided by (Responsible Party):
Arena Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 7, 2021
Actual Study Completion Date : December 7, 2021